Search alternatives:
point decrease » point increase (Expand Search)
teer decrease » greater decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
teer decrease » greater decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1321
-
1322
-
1323
-
1324
-
1325
-
1326
-
1327
-
1328
CXCL12 expression results in decreased proliferation of PDAC cells.
Published 2014“…<p>Population growth of adherent GFP and CXCL12-expressing MiaPaCa2 cells was assessed using the Viacount reagent and flow cytometric cell counting (A–B). CXCL12-expressing cells starved for 24 hours and cultured in both 0% serum (A) or 1% serum (B) containing medium were found to have decreased population growth.…”
-
1329
-
1330
-
1331
-
1332
Loperamide decreases mechanical responsiveness of unmyelinated, nociceptive C-fibers.
Published 2013“…Dashed line indicates threshold assigned to afferents unresponsive to 25 g vF hair. B) Loperamide dose-dependently decreases the responsiveness to suprathreshold mechanical stimuli in both animal groups (ANOVA lesion: F<sub>(3,35)</sub> = 10.3, p<0.001; ANOVA sham: F<sub>(3,16)</sub> = 4.5, p<0.05). …”
-
1333
-
1334
Vasopressin decreases EPSPs in CA2 after LTP induction.
Published 2013“…Vasopressin (AVP 10 nM; 1 min) applied during LTP transiently decreased the EPSP amplitude. …”
-
1335
SPL decreases diabetes-induced oxidative stress in GL and PT.
Published 2017“…Also, SPL diminished diabetes-induced increment of O<sub>2</sub><sup>●―</sup> production (E), lipid peroxidation (F) and protein carbonylation (G) and decreased GSH content (H) in PT (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0177362#pone.0177362.s003" target="_blank">S3 Fig</a>). …”
-
1336
-
1337
Retinoschisin secretion into the conditioned medium is decreased by addition of cytochalasin D.
Published 2013“…(D) Retinoschisin secretion decreases in a dose-dependent manner by treatment of cells with cytochalasin D at concentrations between 0.5 µM and 2 µM. …”
-
1338
-
1339
-
1340